Inotiv, Inc. (NASDAQ:NOTV) CEO Robert Jr. Leasure Sells 22,700 Shares

Inotiv, Inc. (NASDAQ:NOTV) CEO Robert Jr. Leasure sold 22,700 shares of the company’s stock in a transaction that occurred on Friday, January 31st. The shares were sold at an average price of $4.15, for a total value of $94,205.00. Following the sale, the chief executive officer now directly owns 1,030,209 shares in the company, valued at approximately $4,275,367.35. This represents a 2.16 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink.

Inotiv Stock Up 1.4 %

NOTV stock opened at $4.49 on Wednesday. The firm has a market cap of $116.78 million, a price-to-earnings ratio of -1.07 and a beta of 3.58. Inotiv, Inc. has a 1-year low of $1.23 and a 1-year high of $11.42. The firm has a fifty day moving average price of $4.41 and a two-hundred day moving average price of $2.79. The company has a debt-to-equity ratio of 2.29, a current ratio of 1.37 and a quick ratio of 1.22.

Inotiv (NASDAQ:NOTV) last announced its quarterly earnings data on Tuesday, December 3rd. The company reported ($0.16) earnings per share for the quarter. Inotiv had a negative net margin of 22.10% and a negative return on equity of 15.86%. Research analysts predict that Inotiv, Inc. will post -0.75 EPS for the current year.

Hedge Funds Weigh In On Inotiv

Several institutional investors have recently made changes to their positions in NOTV. AlphaCentric Advisors LLC acquired a new position in Inotiv during the 4th quarter valued at approximately $163,000. Calamos Advisors LLC bought a new stake in Inotiv in the fourth quarter valued at $275,000. Nkcfo LLC acquired a new position in shares of Inotiv during the fourth quarter valued at $476,000. Thurston Springer Miller Herd & Titak Inc. grew its position in shares of Inotiv by 612.5% during the fourth quarter. Thurston Springer Miller Herd & Titak Inc. now owns 127,257 shares of the company’s stock worth $527,000 after acquiring an additional 109,397 shares during the last quarter. Finally, Renaissance Technologies LLC increased its holdings in shares of Inotiv by 29.9% in the 2nd quarter. Renaissance Technologies LLC now owns 164,164 shares of the company’s stock worth $273,000 after acquiring an additional 37,800 shares during the period. 18.17% of the stock is owned by institutional investors.

About Inotiv

Inotiv, Inc provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries. It operates through two segment: Discovery and Safety Assessment (DSA), and Research Models and Services (RMS). The DMS segment manufactured scientific instruments for life sciences research and the related software for use by pharmaceutical companies, universities, government research centers, and medical research institutions under the Company's BASi product line.